Logo image of GSIW

GARDEN STAGE LTD (GSIW) Stock Fundamental Analysis

NASDAQ:GSIW - Nasdaq - KYG3730L1077 - Common Stock - Currency: USD

0.751  -0.04 (-5.2%)

Premarket: 0.752 +0 (+0.13%)

Fundamental Rating

2

Taking everything into account, GSIW scores 2 out of 10 in our fundamental rating. GSIW was compared to 230 industry peers in the Capital Markets industry. The financial health of GSIW is average, but there are quite some concerns on its profitability. GSIW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GSIW had negative earnings in the past year.
In the past year GSIW has reported a negative cash flow from operations.
GSIW Yearly Net Income VS EBIT VS OCF VS FCFGSIW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M

1.2 Ratios

GSIW has a worse Return On Assets (-50.37%) than 94.78% of its industry peers.
GSIW's Return On Equity of -113.95% is on the low side compared to the rest of the industry. GSIW is outperformed by 86.96% of its industry peers.
Industry RankSector Rank
ROA -50.37%
ROE -113.95%
ROIC N/A
ROA(3y)-11.42%
ROA(5y)N/A
ROE(3y)-150.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSIW Yearly ROA, ROE, ROICGSIW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -100 -200 -300

1.3 Margins

GSIW has a Gross Margin of 82.46%. This is amongst the best in the industry. GSIW outperforms 86.96% of its industry peers.
GSIW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GSIW Yearly Profit, Operating, Gross MarginsGSIW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for GSIW has been increased compared to 1 year ago.
There is no outstanding debt for GSIW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GSIW Yearly Shares OutstandingGSIW Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
GSIW Yearly Total Debt VS Total AssetsGSIW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -0.73, we must say that GSIW is in the distress zone and has some risk of bankruptcy.
GSIW has a worse Altman-Z score (-0.73) than 84.35% of its industry peers.
There is no outstanding debt for GSIW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.73
ROIC/WACCN/A
WACCN/A
GSIW Yearly LT Debt VS Equity VS FCFGSIW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 5M -5M

2.3 Liquidity

GSIW has a Current Ratio of 1.43. This is a normal value and indicates that GSIW is financially healthy and should not expect problems in meeting its short term obligations.
GSIW has a better Current ratio (1.43) than 63.48% of its industry peers.
A Quick Ratio of 1.43 indicates that GSIW should not have too much problems paying its short term obligations.
The Quick ratio of GSIW (1.43) is better than 63.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.43
GSIW Yearly Current Assets VS Current LiabilitesGSIW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

GSIW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -641.93%.
Looking at the last year, GSIW shows a very negative growth in Revenue. The Revenue has decreased by -47.31% in the last year.
EPS 1Y (TTM)-641.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-251.68%
Revenue 1Y (TTM)-47.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSIW Yearly Revenue VS EstimatesGSIW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GSIW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSIW Price Earnings VS Forward Price EarningsGSIW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSIW Per share dataGSIW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GSIW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GARDEN STAGE LTD

NASDAQ:GSIW (5/21/2025, 8:01:26 PM)

Premarket: 0.752 +0 (+0.13%)

0.751

-0.04 (-5.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.37%
Inst Owner Change-55.8%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.74M
AnalystsN/A
Price TargetN/A
Short Float %0.24%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.4
P/FCF N/A
P/OCF N/A
P/B 2.57
P/tB 2.59
EV/EBITDA N/A
EPS(TTM)-0.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.09
BVpS0.29
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.37%
ROE -113.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.46%
FCFM N/A
ROA(3y)-11.42%
ROA(5y)N/A
ROE(3y)-150.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1141.67%
Cap/Sales 10.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 1.43
Altman-Z -0.73
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)138.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-641.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-251.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-47.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-727.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3101.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3583.68%
OCF growth 3YN/A
OCF growth 5YN/A